Free tool
Heavily traded stocks
We cover 81 companies whose typical session turns over more than $10.00M. The median market value in the group is $2.51B. Across the group, the median move over the past trading day is +0.13%. 96% of the 81 with a 200-day average trade above it. Price change over the past year runs from −20.1% to +292.4% across the middle 80 percent of the group, with a median of +47.9%. Across the group, 3 companies currently carry a tier A volume signal.
Other lists in this group
Table
81 of 7,336 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| MRK | Merck & Co., Inc. | $153.10 | +16.14% | +44.89% | +86.85% |
| AMGN | Amgen Inc. | $440.34 | +12.02% | +36.35% | +56.24% |
| TMO | Thermo Fisher Scientific Inc. | $633.71 | +9.94% | +7.06% | +30.17% |
| ARGX | argenx SE | $1,047.10 | +20.05% | +24.66% | +47.90% |
| CSL.AX | CSL Limited | 173.59 AUD | +35.54% | +2.25% | −16.37% |
| BDX | Becton, Dickinson and Company | $190.21 | +14.35% | +24.91% | +25.97% |
| NTRA | Natera, Inc. | $338.45 | +34.19% | +47.90% | +107.59% |
| IQV | IQVIA Holdings Inc. | $261.51 | +7.64% | +16.04% | +38.51% |
| ILMN | Illumina, Inc. | $224.84 | +16.51% | +67.35% | +125.88% |
| LH | Labcorp Holdings Inc. | $335.72 | +6.84% | +33.74% | +21.14% |
| DGX | Quest Diagnostics Incorporated | $245.00 | +3.84% | +42.24% | +38.12% |
| GMAB.CO | Genmab A/S | 2,196.00 DKK | +17.62% | +9.42% | +36.19% |
| ERF.PA | Eurofins Scientific SE | 74.08 EUR | +7.93% | +20.90% | +15.60% |
| CRL | Charles River Laboratories International, Inc. | $295.10 | +22.74% | +45.79% | +81.27% |
| HALO | Halozyme Therapeutics, Inc. | $107.06 | +28.29% | +52.27% | +46.30% |
| BIO | Bio-Rad Laboratories, Inc. | $388.64 | +17.41% | +27.31% | +32.71% |
| RGEN | Repligen Corporation | $180.30 | +24.05% | +9.70% | +51.67% |
| APGE | Apogee Therapeutics, Inc. | $134.95 | +0.58% | +78.08% | +257.11% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $84.84 | +1.17% | +81.55% | +179.08% |
| TXG | 10x Genomics, Inc. | $64.26 | +36.58% | +286.64% | +358.35% |
| RHC.AX | Ramsay Health Care Limited | 50.09 AUD | +13.17% | +46.21% | +50.11% |
| CAI | Caris Life Sciences, Inc. | $26.82 | +72.03% | −0.59% | −29.83% |
| CNTA | Centessa Pharmaceuticals plc | $40.50 | 0.00% | +70.96% | +143.24% |
| HAE | Haemonetics Corporation | $106.60 | +29.15% | +33.28% | +93.71% |
| HTFL | Heartflow, Inc. | $48.94 | +91.25% | +68.93% | +40.79% |
| ITGR | Integer Holdings Corporation | $125.19 | +24.72% | +63.05% | +15.84% |
| ANN.AX | Ansell Limited | 40.00 AUD | +18.89% | +14.92% | +18.41% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $37.08 | +89.67% | +224.69% | +292.38% |
| IDYA | IDEAYA Biosciences, Inc. | $41.58 | +14.99% | +22.84% | +66.32% |
| ABCL | AbCellera Biologics Inc. | $12.24 | +131.38% | +256.85% | +181.38% |
| CPRX | Catalyst Pharmaceuticals Inc | $31.49 | 0.00% | +36.03% | +55.97% |
| OGN | Organon & Co. | $13.77 | +1.85% | +90.95% | +50.67% |
| PLSE | Pulse Biosciences, Inc. | $48.10 | +35.61% | +259.22% | +203.47% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $8.90 | +29.74% | +161.76% | +281.97% |
| AVAH | Aveanna Healthcare Holdings Inc. | $13.62 | +37.71% | +68.56% | +73.50% |
| ZLAB | Zai Lab Limited | $26.03 | +39.80% | +50.20% | −20.06% |
| ATAI | AtaiBeckley Inc. | $7.39 | +2.92% | +90.96% | +61.71% |
| AMBU-B.CO | Ambu A/S | 78.40 DKK | +8.59% | −9.10% | −19.13% |
| CDNA | CareDx, Inc. | $50.96 | +42.55% | +166.25% | +283.45% |
| RAPP | Rapport Therapeutics, Inc. | $52.50 | +25.12% | +86.77% | +250.70% |
| BAVA.CO | Bavarian Nordic A/S | 218.20 DKK | +23.42% | +13.17% | −7.97% |
| ATRC | AtriCure, Inc. | $48.17 | +21.18% | +22.66% | +29.14% |
| ONT.L | Oxford Nanopore Technologies plc | 183.00 GBP | +62.81% | +42.97% | −2.24% |
| EKTA-B.ST | Elekta AB (publ) | 56.05 SEK | +14.95% | +0.87% | +26.10% |
| XNCR | Xencor, Inc. Common Stock | $28.44 | +42.41% | +90.62% | +254.61% |
| ZYME | Zymeworks Inc. | $29.31 | +29.61% | +10.09% | +96.28% |
| PRGO | Perrigo Company plc | $14.76 | +43.30% | +8.65% | −36.05% |
| VIR | Vir Biotechnology, Inc. | $11.08 | +25.20% | +86.53% | +111.85% |
| BLFS | BioLife Solutions, Inc. | $37.00 | +15.70% | +54.88% | +45.50% |
| INBX | Inhibrx Biosciences, Inc. | $125.34 | +57.30% | +67.03% | +357.45% |
| ETON | Eton Pharmaceuticals, Inc. | $62.62 | +34.20% | +285.12% | +262.38% |
| FBRX | Forte Biosciences, Inc. | $76.99 | +0.44% | +226.09% | +589.87% |
| CGEM | Cullinan Therapeutics, Inc. | $22.85 | +30.80% | +125.79% | +188.15% |
| AMBEA.ST | Ambea AB (publ) | 173.60 SEK | +21.74% | +27.37% | +38.66% |
| KALV | KalVista Pharmaceuticals Inc | $27.00 | 0.00% | +74.64% | +98.68% |
| ANRO | Alto Neuroscience, Inc. | $36.53 | +33.22% | +120.19% | +786.65% |
| OMER | Omeros Corporation | $18.22 | +61.52% | +11.23% | +328.71% |
| CHEMM.CO | ChemoMetec A/S | 496.80 DKK | +15.59% | −26.35% | −3.94% |
| 6523.T | PHC Holdings Corporation | 1,527.00 JPY | +36.71% | +37.93% | +58.42% |
| JANX | Janux Therapeutics, Inc. | $18.89 | +25.93% | +38.39% | −19.10% |
| IMMX | Immix Biopharma, Inc. | $14.07 | +66.71% | +159.12% | +617.86% |
| HELP | Cybin D/B/A Helus Pharma | $13.63 | +79.34% | +64.61% | +77.71% |
| ACHV | Achieve Life Sciences, Inc. | $8.27 | +33.82% | +66.40% | +177.52% |
| 4588.T | Oncolys BioPharma Inc. | 4,080.00 JPY | +66.46% | +173.09% | +539.50% |
| AQST | Aquestive Therapeutics, Inc. | $5.39 | +43.35% | −16.43% | +40.00% |
| SGMT | Sagimet Biosciences Inc. | $10.86 | +49.38% | +81.30% | +39.59% |
| CRNA.OL | Circio Holding ASA | 11.92 NOK | +37.80% | +877.05% | +1733.85% |
| ONCO3.SA | Oncoclínicas do Brasil Serviços Médicos S.A. | 1.92 BRL | +214.75% | −29.41% | −33.79% |
| 219A.T | HEARTSEED INC | 2,435.00 JPY | +48.48% | +34.90% | −30.13% |
| ANCR.L | Animalcare Group PLC | 335.00 GBP | 0.00% | +40.76% | +28.86% |
| 6078.T | Value HR Co.,Ltd. | 1,631.00 JPY | +4.48% | +6.53% | +6.39% |
| 4820.T | EM Systems Co., Ltd. | 602.00 JPY | +6.17% | −22.62% | −18.79% |
| 4577.T | Daito Pharmaceutical Co.,Ltd. | 1,380.00 JPY | +6.73% | +3.16% | +14.45% |
| 4671.T | FALCO HOLDINGS Co., Ltd. | 2,892.00 JPY | +4.82% | +10.10% | +21.78% |
| BVXP.L | Bioventix PLC | 1,750.00 GBP | +15.89% | −5.88% | −30.64% |
| 366A.T | WELLNESS COMMUNICATIONS CORPORA | 1,145.00 JPY | +12.48% | +7.77% | −23.84% |
| 4512.T | Wakamoto Pharmaceutical Co.,Ltd. | 311.00 JPY | +15.61% | +9.43% | +1.97% |
| 4584.T | Kidswell Bio Corporation | 179.00 JPY | +29.71% | −15.57% | −26.03% |
| 4583.T | Chiome Bioscience Inc. | 86.00 JPY | +26.47% | −19.63% | −36.76% |
| PMI | Picard Medical, Inc. | $9.80 | +122.73% | +438.46% | +113.51% |
| SOON.SW | Sonova Holding AG | 245.00 CHF | +10.16% | +17.62% | +6.01% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.